Mizo, drops 60 mg/ml 15 ml 4 pcs

It is used to treat patients with chronic alcoholism and relapse prevention.

Indications

It is used to treat patients with chronic alcoholism and prevent relapse.

Pharmacological effect

Pharmacotherapeutic group:

Special instructions

Reaction to alcohol

Active ingredient

Cyanamide

Composition

Active ingredient:

Cyanamide – 60.0 mg;

Excipients:

Sorbic acid –0.2 mg,

acetic acid – 0.47 mg,

sodium acetate trihydrate – 0.47 mg,

purified water – up to 1.0 ml.

Contraindications

Severe heart disease, respiratory and kidney diseases with decreased function, severe liver disease, pregnancy, breastfeeding, increased individual sensitivity to the drug.

Side Effects

As a rule, the drug is well tolerated if alcohol is not consumed.

Interaction

MIDOZO is not prescribed together with metronidazole, isoniazid, phenotoin and other aldehyde dehydrogenase inhibitors, which may increase the reaction with alcohol.

Overdose

Symptoms of overdose are not described, increased side effects are possible. If too large doses of the drug are taken, gastric lavage and symptomatic treatment aimed at maintaining the functions of the liver, respiratory and cardiovascular system are recommended; monitoring of the hematocrit and, if necessary, blood transfusions are also necessary.

Storage conditions

In a place protected from light at a temperature not exceeding 25 ͦC.

Keep out of the reach of children.

Shelf life

2 years.

Manufacturer

Special Products Line S.P.A, Italy